JPRN-UMIN000000931
Completed
未知
Clinical study to investigate safety and efficacy on combination of gemcitabine and autologous gamma/delta T cell transfer therapy after resection of pancreatic cancer - Clinical study of gemcitabine and gamma/delta T cell therapy after resection of pancreatic cancer
ConditionsPancreatic cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- The University of Tokyo Hospital
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have: \- Pulmonary fibrosis or interstitial pneumonia, or their history, or predisposition to them; \- Active enteritis, autoimmune diseases, and/or infections; \- Other cancers; \- Other serious complications; \- Continuous systemic administration of steroids.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study to investigate safety and efficacy on a combined use of rituximab and auto-gamma/delta T cell therapy for CD20-positive B-cell lymphoma.CD20-positive B-cell lymphomaJPRN-UMIN000003641Japanese Red Cross Medical Center15
Completed
Phase 1
Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cellsMalignant GliomaJPRN-UMIN000001903Osaka National Hospital, National Hospital Organization15
Active, not recruiting
Phase 3
A Clinical Study to Evaluate the Safety and Efficacy of Livercure Tablets on Patients with Liver Cirrhosis.Health Condition 1: K745- Biliary cirrhosis, unspecifiedHealth Condition 2: K745- Biliary cirrhosis, unspecifiedCTRI/2022/07/043725Jammi Pharmaceuticals Pvt Ltd
Completed
Phase 2
Clinical study to evaluate the safety and efficacy of cinnamon in the management of non-alcoholic fatty liver diseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedCTRI/2021/03/032039Central council for research in Unani medicine New dehli60
Completed
Not Applicable
To study the effect of Tab HFO-O2 in fatty individuals.CTRI/2016/07/007067Baidyanath Bhavan Pvt Ltd